Biocon Biologics Inc. et al. vs. Regeneron Pharmaceuticals, Inc.
Explore the PTAB proceeding IPR2024-00298 filed by Biocon Biologics Inc. et al. on 2023-12-18. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2024-00298
Filing Date
2023-12-18
Accorded Filing Date
2023-12-18
Institution Decision Date
2024-01-31
Last Modified Date
2025-02-12
Proceeding Type
IPR
Termination Date
2024-07-23
Trial Status
Terminated-Adverse Judgment
Parties & Counsel
Petitioner
Biocon Biologics Inc. et al.
Represented By
Molino, Paulet alPatent Owner / Respondent
Regeneron Pharmaceuticals, Inc.
Represented By
Brausa, Adamet alTribunal & Venue
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Patent Information
Respondent Application Number
17352892
Respondent Patent Number
11253572
External Links
Respondent Inventor
George YANCOPOULOS
Respondent Tech Center
TC 1600 - Biotechnology & Organic Chemistry
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Firm
/ Entity Name
A&P - Regeneron (Prosecution)
Customer
Number
191459
Address
601 Massachusetts Ave., NW, Washington, DC, 20001-3743, UNITED STATES
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 41408 | David Marsh | 202-942-5068 |
| 48001 | Thomas Triolo | 914-847-1612 |
| 48921 | Stephen Gaudet | 914-847-7376 |
| 50370 | Neil Miyamoto | 914-847-7175 |
| 50437 | Frank Cottingham | 914-593-1116 |
| 58583 | Brian Cocca | 914-847-1421 |
| 58714 | Ilona Gont | 914-847-1304 |
| 59668 | Brandon Schurter | 914-847-7000 |
Proceeding Documents
84
3001
Ex. 3004 Exhibit
2024-07-23
FILING PARTY: BOARD
11
Adverse judgment: post-institution ADVRSJUDG
2024-07-23
FILING PARTY: BOARD
3001
Ex. 3005 Exhibit
2024-07-23
FILING PARTY: BOARD
10
Petitioner's Amended Mandatory Notices NOTICE
2024-05-03
FILING PARTY: PETITIONER
9
Institution Decision: Joined OTHER
2024-01-31
FILING PARTY: BOARD